References
- Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N.J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I.F., Fojo, T., Siderov, J., Williamson, S., Camporesi, S., McVie, J.G., Purushotham, A.D., Naredi, P., Eggermont, A., Brennan, M.F., Steinberg, M.L., De Ridder, M., McCloskey, S.A., Verellen, D., Roberts, T., Storme, G., Hicks, R.J., Ell, P.J., Hirsch, B.R., Carbone, D.P., Schulman, K.A., Catchpole, P., Taylor, D., Geissler, J., Brinker, N.G., Meltzer, D., Kerr, D., Aapro, M. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011, 12, 933–980.
- Thomas, J.S., Bruce, E.H. Bending the cost curve in cancer care. N Engl J Med 2011, 364, 2060–2065.
- Stark, C.J. The economic burden of cancer in Europe. EJHP Practice. 2006, 12, 53–56.
- Mack, J.W., Weeks, J.C., Wright, A.A., Block, S.D., Prigerson, H.G. End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol 2010, 28, 1203–1208.
- Zhang, B., Wright, A.A., Huskamp, H.A., Nilsson, M.E., Maciejewski, M.L., Earle, C.C., Block, S.D., Maciejewski, P.K., Prigerson, H.G. Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med 2009, 169, 480–488.
- Earle, C.C., Landrum, M.B., Souza, J.M., Neville, B.A., Weeks, J.C., Ayanian, J.Z. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 2008, 26, 3860–3866.
- Temel, J.S., Greer, J.A., Muzikansky, A., Gallagher, E.R., Admane, S., Jackson, V.A., Dahlin, C.M., Blinderman, C.D., Jacobsen, J., Pirl, W.F., Billings, J.A., Lynch, T.J. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010, 363, 733–742.
- Trojniak, M.P., Palozzo, A.C., Mazurek, M., Jirillo, A. Sorafenib in hepatocellular carcinoma – a post marketing evaluation. Immunopharmacol Immunotoxicol 2011. Oct 8. [Epub ahead of print]
- Jirillo, A., Boscaro, M., Pasetto, L.M., Monfardini, S. Chemotherapy at the end of life: an open question. Tumori 2005, 91, 104–105.